PeptideDB

SW044248 522650-83-5

SW044248 522650-83-5

CAS No.: 522650-83-5

SW044248 is a novel, potent and selective Topoisomerase I inhibitor that was identified through a screen for chemicals s
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

SW044248 is a novel, potent and selective Topoisomerase I inhibitor that was identified through a screen for chemicals selectively toxic for non-small cell lung cancer (NSCLC) cell lines. It was discovered that in sensitive cells, but not in insensitive cells, SW044248 quickly inhibits macromolecular synthesis. A panel of 74 NSCLC cell lines was treated with SW044248, which was nontoxic to immortalized human bronchial cell lines and killed about 15% of them. SW044248 inhibited topoisomerase 1 (Top1) but not topoisomerase 2, and in sensitive HCC4017 cells, the acute transcriptional response to the drug correlated significantly with topoisomerase inhibitors. Camptothecin did not exhibit the same selective toxicity as SW044248, and SW044248 inhibited Top1 in a different way than camptothecin. Although deleting Top1 was eventually toxic, it did provide some protection against SW044248 for cells when done so via siRNA. siRNA to CDKN1A sensitized cells resistant to SW044248, and those cells upregulated CDKN1A in response to the compound. Thus, at least part of the differential sensitivity of NSCLC cells to SW044248 is the ability to upregulate CDKN1A.



Physicochemical Properties


Molecular Formula C22H23N5O2S
Molecular Weight 421.52
Exact Mass 421.157
Elemental Analysis C, 62.69; H, 5.50; N, 16.61; O, 7.59; S, 7.61
CAS # 522650-83-5
Related CAS #
522650-83-5
PubChem CID 3152990
Appearance Light yellow to yellow solid powder
Density 1.3±0.1 g/cm3
Index of Refraction 1.675
LogP 4.48
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 6
Rotatable Bond Count 7
Heavy Atom Count 30
Complexity 582
Defined Atom Stereocenter Count 0
SMILES

S(C1N=NC2=C(N=1)N(C([H])([H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C12)C([H])(C(N([H])C1=C([H])C([H])=C([H])C([H])=C1OC([H])([H])[H])=O)C([H])([H])C([H])([H])[H]

InChi Key PEVRGVRHMMZNGI-UHFFFAOYSA-N
InChi Code

InChI=1S/C22H23N5O2S/c1-4-18(21(28)23-15-11-7-9-13-17(15)29-3)30-22-24-20-19(25-26-22)14-10-6-8-12-16(14)27(20)5-2/h6-13,18H,4-5H2,1-3H3,(H,23,28)
Chemical Name

2-[(5-ethyl-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(2-methoxyphenyl)butanamide
Synonyms

SW044248; SW 044248; SW-044248
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets Topoisomerase I
ln Vitro

SW044248 is a non-canonical Top1 inhibitor that is harmful to specific NSCLC cell lines only. There is no impact of SW044248 on Top2. HBEC30KT and HCC44 cells are insensitive to SW044248 (2, 5, 10 μM), but sensitive cells (HCC4017 and H292 cells) are rapidly inhibited in transcription, translation, and DNA synthesis. Via the kinases GCN2 and PKR, SW044248 (10 μM) quickly initiates the integrated stress response. The toxicity of SW044248 is mitigated in HCC4017 cells by Top1 inhibition. Because p21CDKN1A is overexpressed in HBEC30KT and HCC44 cell lines, SW044248 (5, 10 μM) has no effect on them[1]. In 18 out of 74 NSCLC lines, SW044248 is selectively toxic[2].

ln Vivo

Cell Assay In wells of 96-well plates, 100 μL of 50,000 cells/mL cell suspensions of distinct cell lines are added. The following day, 100 μL of cell medium was added to each well, substituting 2X concentration of either SW044248, camptothecin, or DMSO in triplicate. The wells' ATP concentration is determined using CelTiter-Glo after 96 and 120 hours. With the aid of a plate reader, luminescence is measured[1].
Animal Protocol


References

[1]. A Novel Inhibitor of Topoisomerase I Is Selectively Toxic for a Subset of Non-Small Cell Lung Cancer Cell Lines. Mol Cancer Ther. 2016 Jan;15(1):23-36.

[2]. Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer. Cell. 2013 Oct 24;155(3):552-66.


Solubility Data


Solubility (In Vitro)
DMSO: ≥ 30 mg/mL
Water: N/A
Ethanol: N/A
Solubility (In Vivo) Solubility in Formulation 1: ≥ 1.25 mg/mL (2.97 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.3724 mL 11.8618 mL 23.7237 mL
5 mM 0.4745 mL 2.3724 mL 4.7447 mL
10 mM 0.2372 mL 1.1862 mL 2.3724 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.